J.P. Morgan Equity Research SA vs UBS IBD SA

First thoughts on this decision? I guess ER would be better for HF exit ops in the long term while IBD is more suited for PE?

Would the J P Morgan name help over UBS regardless of what I wanted to do afterwards?

8 Comments
 

JPM has a very good sell-side ER platform, if we go by II rankings and how many resources they put into their research department (vs. something like GS where they apparently don't give a fuck about their ER franchise). On the other hand, the odds of getting a FT offer for ER post-SA are lower, they run pretty lean.

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 
Best Response

I would think your options look something like this

ER SA -> ER FT 2/3 years --> HF ER SA -> ER FT 2/3 years --> ER Forever ER SA -> ER FT 2/3 years --> B-School --> HF/PE

&

ER SA -> anything full time

IBD SA ->IBD FT 2 years --> HF/PE/B-School/Pre-Mba roles

While ER does exit to HF, the consensus is that IBD will likely still have an advantage even at most HFs.

If you can take the lifestyle, I would say IBD is always the clear choice for setting up the best exit ops and best chance at a FT offer. Just my opinion.

 
sk8247365I would think your options look something like this

ER SA -> ER FT 2/3 years --> HF ER SA -> ER FT 2/3 years --> ER Forever ER SA -> ER FT 2/3 years --> B-School --> HF/PE

&

ER SA -> anything full time

IBD SA ->IBD FT 2 years --> HF/PE/B-School/Pre-Mba roles

While ER does exit to HF, the consensus is that IBD will likely still have an advantage even at most HFs.

If you can take the lifestyle, I would say IBD is always the clear choice for setting up the best exit ops and best chance at a FT offer. Just my opinion.

I like that breakdown.

Under my tutelage, you will grow from boys to men. From men into gladiators. And from gladiators into SWANSONS.
 

Voluptas mollitia repellendus cumque dolores quis a et. Necessitatibus hic non fuga expedita qui est voluptate. Fugiat sed dolor praesentium nihil voluptatem eum praesentium.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Goldman Sachs 01 97.8%
  • Guggenheim Partners No 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (23) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (81) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”